Concetti Chiave
Aladdin, a novel end-to-end workflow, can reliably provide high-resolution 3D maps of left atrial displacements and strains from cardiac cine MRI, enabling comprehensive characterization of left atrial function.
Sintesi
This study presents Aladdin, a novel workflow for the comprehensive analysis of left atrial (LA) motion and deformation using high-resolution 3D cardiac cine MRI. Aladdin includes:
- An online learning segmentation neural network (nnU-Net) to accurately segment the LA across the cardiac cycle.
- An online weakly supervised learning image registration neural network (Aladdin-R) to estimate the LA displacement vector fields (DVFs) across the cardiac cycle.
- An algorithm to calculate regional LA principal strains from the estimated DVFs.
- The construction of an atlas of LA DVFs and strains using data from 10 healthy volunteers.
- Proof-of-concept characterization of regional LA strains in 8 cardiovascular disease (CVD) patients, including 2 with reduced left ventricular ejection fraction (LVEF↓).
The results show that Aladdin can accurately track the LA wall and characterize its motion and deformation. Global LA function markers assessed with Aladdin agree well with estimates from 2D cine MRI. A more marked active contraction phase was observed in the healthy cohort, while the CVD LVEF↓ group showed overall reduced LA function. Aladdin is uniquely able to identify LA regions with abnormal deformation metrics that may indicate focal pathology. This framework has the potential to provide novel clinical biomarkers of atrial pathophysiology.
Statistiche
"The healthy cohort had average DVF magnitudes of 0.67 ± 0.40 mm and principal strain values of 0.04 ± 0.04 across the cardiac cycle."
"The CVD cases had slightly higher averages of 0.71 ± 0.43 mm and 0.05 ± 0.04."
"The CVD LVEF↓ cases had much lower values of 0.34 ± 0.15 mm and 0.02 ± 0.02."
Citazioni
"Aladdin is uniquely able to identify LA regions with abnormal deformation metrics that may indicate focal pathology."
"This framework has the potential to provide novel clinical biomarkers of atrial pathophysiology."